M57 Prolactinomas

Program: Meet-the-Professor Sessions
Clinical Session
Monday, April 4, 2016: 9:00 AM-9:45 AM
Room 252 (BCEC)
Mark E Molitch, MD, Northwestern University Feinberg School of Medicine, Chicago, IL

MEM: own stock, Amgen, Investigator, Bayer, Inc., Investigator, Ipsen, Advisory Group Member, Jansen Pharmaceuticals, Advisory Group Member, Johnson &Johnson, Investigator, Novartis Pharmaceuticals, Investigator, Novo Nordisk, Advisory Group Member, Merck & Co., Advisory Group Member, Pfizer, Inc..


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire